1121 related articles for article (PubMed ID: 31078459)
1. Two-view digital breast tomosynthesis versus digital mammography in a population-based breast cancer screening programme (To-Be): a randomised, controlled trial.
Hofvind S; Holen ÅS; Aase HS; Houssami N; Sebuødegård S; Moger TA; Haldorsen IS; Akslen LA
Lancet Oncol; 2019 Jun; 20(6):795-805. PubMed ID: 31078459
[TBL] [Abstract][Full Text] [Related]
2. One-view breast tomosynthesis versus two-view mammography in the Malmö Breast Tomosynthesis Screening Trial (MBTST): a prospective, population-based, diagnostic accuracy study.
Zackrisson S; Lång K; Rosso A; Johnson K; Dustler M; Förnvik D; Förnvik H; Sartor H; Timberg P; Tingberg A; Andersson I
Lancet Oncol; 2018 Nov; 19(11):1493-1503. PubMed ID: 30322817
[TBL] [Abstract][Full Text] [Related]
3. Integration of 3D digital mammography with tomosynthesis for population breast-cancer screening (STORM): a prospective comparison study.
Ciatto S; Houssami N; Bernardi D; Caumo F; Pellegrini M; Brunelli S; Tuttobene P; Bricolo P; Fantò C; Valentini M; Montemezzi S; Macaskill P
Lancet Oncol; 2013 Jun; 14(7):583-9. PubMed ID: 23623721
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer screening with tomosynthesis (3D mammography) with acquired or synthetic 2D mammography compared with 2D mammography alone (STORM-2): a population-based prospective study.
Bernardi D; Macaskill P; Pellegrini M; Valentini M; Fantò C; Ostillio L; Tuttobene P; Luparia A; Houssami N
Lancet Oncol; 2016 Aug; 17(8):1105-1113. PubMed ID: 27345635
[TBL] [Abstract][Full Text] [Related]
5. Digital breast tomosynthesis plus synthesised mammography versus digital screening mammography for the detection of invasive breast cancer (TOSYMA): a multicentre, open-label, randomised, controlled, superiority trial.
Heindel W; Weigel S; Gerß J; Hense HW; Sommer A; Krischke M; Kerschke L;
Lancet Oncol; 2022 May; 23(5):601-611. PubMed ID: 35427470
[TBL] [Abstract][Full Text] [Related]
6. The TOMMY trial: a comparison of TOMosynthesis with digital MammographY in the UK NHS Breast Screening Programme--a multicentre retrospective reading study comparing the diagnostic performance of digital breast tomosynthesis and digital mammography with digital mammography alone.
Gilbert FJ; Tucker L; Gillan MG; Willsher P; Cooke J; Duncan KA; Michell MJ; Dobson HM; Lim YY; Purushothaman H; Strudley C; Astley SM; Morrish O; Young KC; Duffy SW
Health Technol Assess; 2015 Jan; 19(4):i-xxv, 1-136. PubMed ID: 25599513
[TBL] [Abstract][Full Text] [Related]
7. Digital breast tomosynthesis plus synthesised images versus standard full-field digital mammography in population-based screening (TOSYMA): protocol of a randomised controlled trial.
Weigel S; Gerss J; Hense HW; Krischke M; Sommer A; Czwoydzinski J; Lenzen H; Kerschke L; Spieker K; Dickmaenken S; Baier S; Urban M; Hecht G; Heidinger O; Kieschke J; Heindel W
BMJ Open; 2018 May; 8(5):e020475. PubMed ID: 29764880
[TBL] [Abstract][Full Text] [Related]
8. Digital Mammography versus Digital Mammography Plus Tomosynthesis in Breast Cancer Screening: The Oslo Tomosynthesis Screening Trial.
Skaane P; Bandos AI; Niklason LT; Sebuødegård S; Østerås BH; Gullien R; Gur D; Hofvind S
Radiology; 2019 Apr; 291(1):23-30. PubMed ID: 30777808
[TBL] [Abstract][Full Text] [Related]
9. Interval and Consecutive Round Breast Cancer after Digital Breast Tomosynthesis and Synthetic 2D Mammography versus Standard 2D Digital Mammography in BreastScreen Norway.
Hovda T; Holen ÅS; Lång K; Albertsen JL; Bjørndal H; Brandal SHB; Sahlberg KK; Skaane P; Suhrke P; Hofvind S
Radiology; 2020 Feb; 294(2):256-264. PubMed ID: 31821118
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer detection using single-reading of breast tomosynthesis (3D-mammography) compared to double-reading of 2D-mammography: Evidence from a population-based trial.
Houssami N; Bernardi D; Pellegrini M; Valentini M; Fantò C; Ostillio L; Tuttobene P; Luparia A; Macaskill P
Cancer Epidemiol; 2017 Apr; 47():94-99. PubMed ID: 28192742
[TBL] [Abstract][Full Text] [Related]
11. MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicentre, randomised, controlled trial.
Saadatmand S; Geuzinge HA; Rutgers EJT; Mann RM; de Roy van Zuidewijn DBW; Zonderland HM; Tollenaar RAEM; Lobbes MBI; Ausems MGEM; van 't Riet M; Hooning MJ; Mares-Engelberts I; Luiten EJT; Heijnsdijk EAM; Verhoef C; Karssemeijer N; Oosterwijk JC; Obdeijn IM; de Koning HJ; Tilanus-Linthorst MMA;
Lancet Oncol; 2019 Aug; 20(8):1136-1147. PubMed ID: 31221620
[TBL] [Abstract][Full Text] [Related]
12. Artificial intelligence-supported screen reading versus standard double reading in the Mammography Screening with Artificial Intelligence trial (MASAI): a clinical safety analysis of a randomised, controlled, non-inferiority, single-blinded, screening accuracy study.
Lång K; Josefsson V; Larsson AM; Larsson S; Högberg C; Sartor H; Hofvind S; Andersson I; Rosso A
Lancet Oncol; 2023 Aug; 24(8):936-944. PubMed ID: 37541274
[TBL] [Abstract][Full Text] [Related]
13. Annual mammographic screening to reduce breast cancer mortality in women from age 40 years: long-term follow-up of the UK Age RCT.
Duffy S; Vulkan D; Cuckle H; Parmar D; Sheikh S; Smith R; Evans A; Blyuss O; Johns L; Ellis I; Sasieni P; Wale C; Myles J; Moss S
Health Technol Assess; 2020 Oct; 24(55):1-24. PubMed ID: 33141657
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of hybrid digital breast tomosynthesis/digital mammography compared to digital mammography in women presenting for routine screening at Maroondah BreastScreen: Study protocol for a co-designed, non-randomised prospective trial.
Houssami N; Lockie D; Giles M; Doncovio S; Marr G; Taylor D; Li T; Nickel B; Marinovich ML
Breast; 2024 Apr; 74():103692. PubMed ID: 38422623
[TBL] [Abstract][Full Text] [Related]
15. Incremental effect from integrating 3D-mammography (tomosynthesis) with 2D-mammography: Increased breast cancer detection evident for screening centres in a population-based trial.
Caumo F; Bernardi D; Ciatto S; Macaskill P; Pellegrini M; Brunelli S; Tuttobene P; Bricolo P; Fantò C; Valentini M; Montemezzi S; Houssami N
Breast; 2014 Feb; 23(1):76-80. PubMed ID: 24316152
[TBL] [Abstract][Full Text] [Related]
16. Screening outcome for consecutive examinations with digital breast tomosynthesis versus standard digital mammography in a population-based screening program.
Hovda T; Brandal SHB; Sebuødegård S; Holen ÅS; Bjørndal H; Skaane P; Hofvind S
Eur Radiol; 2019 Dec; 29(12):6991-6999. PubMed ID: 31187221
[TBL] [Abstract][Full Text] [Related]
17. Two-view digital breast tomosynthesis screening with synthetically reconstructed projection images: comparison with digital breast tomosynthesis with full-field digital mammographic images.
Skaane P; Bandos AI; Eben EB; Jebsen IN; Krager M; Haakenaasen U; Ekseth U; Izadi M; Hofvind S; Gullien R
Radiology; 2014 Jun; 271(3):655-63. PubMed ID: 24484063
[TBL] [Abstract][Full Text] [Related]
18. Cost differences between digital tomosynthesis and standard digital mammography in a breast cancer screening programme: results from the To-Be trial in Norway.
Moger TA; Swanson JO; Holen ÅS; Hanestad B; Hofvind S
Eur J Health Econ; 2019 Nov; 20(8):1261-1269. PubMed ID: 31399773
[TBL] [Abstract][Full Text] [Related]
19. A randomized controlled trial of digital breast tomosynthesis versus digital mammography in population-based screening in Bergen: interim analysis of performance indicators from the To-Be trial.
Aase HS; Holen ÅS; Pedersen K; Houssami N; Haldorsen IS; Sebuødegård S; Hanestad B; Hofvind S
Eur Radiol; 2019 Mar; 29(3):1175-1186. PubMed ID: 30159620
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
